Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 80.56% is 124% above its 5-year average of 35.92%, around the middle of its 5-year range (-103.82%–394.79%).
0.94% below its 12-month average of 81.33%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -69.75%.
NET PROFIT MARGIN
80.56%
NET PROFIT MARGIN AVG TTM
81.33%
NET PROFIT MARGIN AVG 3Y
45.11%
NET PROFIT MARGIN AVG 5Y
35.92%
NET PROFIT MARGIN AVG 10Y
56.41%
NET PROFIT MARGIN AVG 15Y
33.96%
NET PROFIT MARGIN AVG 20Y
-139.20%
CURRENT VS TTM AVG
-0.94%
CURRENT VS 3Y AVG
+78.59%
CURRENT VS 5Y AVG
+124.25%
CURRENT VS 10Y AVG
+42.80%
CURRENT VS 15Y AVG
+137.25%
CURRENT VS 20Y AVG
+157.87%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Innoviva, Inc.
Market Cap
$1.55B
Net Profit Margin
80.56%
TTM Avg
81.33%
3Y Avg
45.11%
5Y Avg
35.92%
Market Cap
$1.54B
Net Profit Margin
-1350.73%
TTM Avg
-1059.67%
3Y Avg
-1046.38%
5Y Avg
-742.65%
Market Cap
$1.54B
Net Profit Margin
21.25%
TTM Avg
9.48%
3Y Avg
-48.31%
5Y Avg
-19.09%
Market Cap
$1.52B
Net Profit Margin
12.02%
TTM Avg
-7.78%
3Y Avg
-15.24%
5Y Avg
-11964.64%
Market Cap
$1.51B
Net Profit Margin
6.57%
TTM Avg
5.15%
3Y Avg
3.47%
5Y Avg
4.27%
Market Cap
$1.49B
Net Profit Margin
-16.75%
TTM Avg
-1.75%
3Y Avg
-3.69%
5Y Avg
-6.61%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.55B | 80.56% | 81.33% | 45.11% | 35.92% |
| uniQure N.V. (QURE)vs › | $1.54B | -1350.73% | -1059.67% | -1046.38% | -742.65% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 21.25% | 9.48% | -48.31% | -19.09% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 12.02% | -7.78% | -15.24% | -11964.64% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.51B | 6.57% | 5.15% | 3.47% | 4.27% |
| Omnicell, Inc. (OMCL)vs › | $1.59B | 3.13% | 0.65% | -0.01% | 1.74% |
| GH Research PLC (GHRS)vs › | $1.49B | 0.00% | 0.00% | 0.00% | 0.00% |
| Certara, Inc. (CERT)vs › | $1.49B | -16.75% | -1.75% | -3.69% | -6.61% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.62B | -140.43% | -164.31% | -442.76% | -354.21% |
Operating Margin
36.7%
Net Profit Margin
80.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -69.75% |
| 2026-03-31 | 190.41% |
| 2025-12-31 | 139.06% |
| 2025-09-30 | 83.40% |
| 2025-06-30 | 63.51% |
| 2025-03-31 | -52.56% |
| 2024-12-31 | 22.15% |
| 2024-09-30 | 1.36% |
| 2024-06-30 | -33.56% |
| 2024-03-31 | 47.14% |
| 2023-12-31 | 71.68% |
| 2023-09-30 | 121.99% |
| 2023-06-30 | 1.58% |
| 2023-03-31 | 45.65% |
| 2022-12-31 | -103.82% |
| 2022-09-30 | 394.79% |
| 2022-06-30 | 0.87% |
| 2022-03-31 | 17.51% |
| 2021-12-31 | 9.61% |
| 2021-09-30 | 74.02% |
| 2021-06-30 | 88.24% |
| 2021-03-31 | 110.06% |
| 2020-12-31 | 59.58% |
| 2020-09-30 | 31.82% |
| 2020-06-30 | 97.34% |
| 2020-03-31 | 83.17% |
| 2019-12-31 | 60.48% |
| 2019-09-30 | 60.54% |
| 2019-06-30 | 58.87% |
| 2019-03-31 | 61.23% |
| 2018-12-31 | 330.29% |
| 2018-09-30 | 76.34% |
| 2018-06-30 | 81.43% |
| 2018-03-31 | 56.47% |
| 2017-12-31 | 83.98% |
| 2017-09-30 | 48.86% |
| 2017-06-30 | 60.02% |
| 2017-03-31 | 41.60% |
| 2016-12-31 | 58.40% |
| 2016-09-30 | 45.13% |
| 2016-06-30 | 44.95% |
| 2016-03-31 | 18.34% |
| 2015-12-31 | 18.83% |
| 2015-09-30 | -33.80% |
| 2015-06-30 | -73.30% |
| 2015-03-31 | -154.68% |
| 2014-12-31 | -218.76% |
| 2014-09-30 | -2129.23% |
| 2014-06-30 | -6805.57% |
| 2014-03-31 | -41032.12% |
| 2013-12-31 | -3511.18% |
| 2013-09-30 | -10702.73% |
| 2013-06-30 | -2745.21% |
| 2013-03-31 | -2779.76% |
| 2012-12-31 | -540.26% |
| 2012-09-30 | -2426.01% |
| 2012-06-30 | -2595.80% |
| 2012-03-31 | 66.56% |
| 2011-12-31 | -690.17% |
| 2011-09-30 | -476.22% |
| 2011-06-30 | -392.00% |
| 2011-03-31 | -358.03% |
| 2010-12-31 | -278.00% |
| 2010-09-30 | -400.26% |
| 2010-06-30 | -332.15% |
| 2010-03-31 | -394.40% |
| 2009-12-31 | -581.11% |
| 2009-09-30 | -402.23% |
| 2009-06-30 | -394.90% |
| 2009-03-31 | -201.35% |
| 2008-12-31 | -267.78% |
| 2008-09-30 | -348.86% |
| 2008-06-30 | -490.94% |
| 2008-03-31 | -527.26% |
| 2007-12-31 | -587.18% |
| 2007-09-30 | -570.89% |
| 2007-06-30 | -850.61% |
| 2007-03-31 | -916.08% |
| 2006-12-31 | -767.48% |
| 2006-09-30 | -683.92% |
| 2006-06-30 | -857.45% |
| 2006-03-31 | -1139.48% |
| 2005-12-31 | -1249.59% |
| 2005-09-30 | -1257.02% |
| 2005-06-30 | -1088.77% |
| 2005-03-31 | -1140.77% |
| 2004-12-31 | -1064.64% |
| 2004-09-30 | -845.16% |
| 2004-06-30 | -1710.72% |
